BioScrip®, Inc. (NASDAQ: BIOS) (the “Company”) today announced 2014 fourth quarter financial results. Fourth quarter revenue from continuing operations was $253.7 million and the net loss from continuing operations was $61.9 million, or $0.90 per basic and diluted shar…
Source: BioScrip’s total revenue increases $28.2 million to 2.5% in fourth quarter 2014
Monday, March 2, 2015
BioScrip’s total revenue increases $28.2 million to 2.5% in fourth quarter 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment